Mesenchymal stem cells attenuate MRI-identifiable injury, protect white matter, and improve long-term functional outcomes after neonatal focal stroke in rats

Journal of Neuroscience Research

Volumn 95, Issue 5, 2017, Pages 1225-1236

  van Velthoven, Cindy T ^a   Dzietko, Mark ^a   Wendland, Michael F ^a   Derugin, Nikita ^a   Faustino, Joel ^a   Heijnen, Cobi J ^b   Ferriero, Donna M ^a   Vexler, Zinaida S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

axon; brain repair; diffusion tensor imaging; fractional anisotropy; middle cerebral artery occlusion; perinatal stroke

Indexed keywords

MYELIN BASIC PROTEIN; BROXURIDINE; GLIAL FIBRILLARY ACIDIC PROTEIN; LECTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTOSIS; AXONAL INJURY; CONTROLLED STUDY; DIFFUSION TENSOR IMAGING; EXPERIMENTAL STROKE; FEMALE; FRACTIONAL ANISOTROPY; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MIDDLE CEREBRAL ARTERY OCCLUSION; NEWBORN; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT; WHITE MATTER INJURY; AGE; ANALYSIS OF VARIANCE; ANIMAL; BIOLOGICAL THERAPY; CEREBRAL ARTERY DISEASE; DIAGNOSTIC IMAGING; DISEASE MODEL; GENE EXPRESSION REGULATION; IMAGE PROCESSING; MESENCHYMAL STROMA CELL; METABOLISM; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PHYSIOLOGY; PROCEDURES; PSYCHOMOTOR DISORDER; SPRAGUE DAWLEY RAT; WHITE MATTER;

AGE FACTORS; ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; BROMODEOXYURIDINE; CELL- AND TISSUE-BASED THERAPY; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GLIAL FIBRILLARY ACIDIC PROTEIN; IMAGE PROCESSING, COMPUTER-ASSISTED; INFARCTION, MIDDLE CEREBRAL ARTERY; LECTINS; MAGNETIC RESONANCE IMAGING; MESENCHYMAL STROMAL CELLS; MYELIN BASIC PROTEIN; PSYCHOMOTOR DISORDERS; RATS; RATS, SPRAGUE-DAWLEY; WHITE MATTER;

EID: 84998673820     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.23954     Document Type: Article

References (52)

1. Arai K, Lok J, Guo S, Hayakawa K, Xing C, Lo EH. 2011. Cellular mechanisms of neurovascular damage and repair after stroke. J Child Neurol 26:1193–1198.
2. Back SA, Gan X, Li Y, Rosenberg PA, Volpe JJ. 1998. Maturation-dependent vulnerability of oligodendrocytes to oxidative stress-induced death caused by glutathione depletion. J Neurosci 18:6241–6253.
3. Back SA, Han BH, Luo NL, Chricton CA, Xanthoudakis S, Tam J, Arvin KL, Holtzman DM. 2002. Selective vulnerability of late oligodendrocyte progenitors to hypoxia-ischemia. J Neurosci 22:455–463.
4. Back SA, Riddle A, McClure MM. 2007. Maturation-dependent vulnerability of perinatal white matter in premature birth. Stroke 38(2 Suppl):724–730.
5. Billiards SS, Haynes RL, Folkerth RD, Borenstein NS, Trachtenberg FL, Rowitch DH, Ligon KL, Volpe JJ, Kinney HC. 2008. Myelin abnormalities without oligodendrocyte loss in periventricular leukomalacia. Brain Pathol 18:153–163.
6. Bliss TM, Andres RH, Steinberg GK. 2010. Optimizing the success of cell transplantation therapy for stroke. Neurobiol Dis 37:275–283.
7. Cengiz P, Uluc K, Kendigelen P, Akture E, Hutchinson E, Song C, Zhang L, Lee, Budoff GE, Meyerand E, et al. 2011. Chronic neurological deficits in mice after perinatal hypoxia and ischemia correlate with hemispheric tissue loss and white matter injury detected by MRI. Dev Neurosci 33:270–279.
8. Chan KC, Khong PL, Lau HF, Cheung PT, Wu EX. 2009. Late measures of microstructural alterations in severe neonatal hypoxic-ischemic encephalopathy by MR diffusion tensor imaging. Int J Dev Neurosci 27:607–615.
9. Chen J, Li Y, Katakowski M, Chen X, Wang L, Lu D, Lu M, Gautam SC, Chopp M. 2003. Intravenous bone marrow stromal cell therapy reduces apoptosis and promotes endogenous cell proliferation after stroke in female rat. J Neurosci Res 73:778–786.
10. Daadi MM, Davis AS, Arac A, Li Z, Maag AL, Bhatnagar R, Jiang K, Sun G, Wu JC, Steinberg GK. 2010. Human neural stem cell grafts modify microglial response and enhance axonal sprouting in neonatal hypoxic-ischemic brain injury. Stroke 41:516–523.
11. Derugin N, Wendland M, Muramatsu K, Roberts T, Gregory G, Ferriero D, Vexler Z. 2000. Evolution of brain injury after transient middle cerebral artery occlusion in neonatal rat. Stroke 31:1752–1761.
12. Derugin N, Dingman A, Wendland M, Fox C, Vexler ZS. 2005. Magnetic resonance imaging as a surrogate measure for histological sub-chronic endpoint in a neonatal rat stroke model. Brain Res 1066:49–56.
13. Donega V, Nijboer CH, Braccioli L, Slaper-Cortenbach I, Kavelaars A, van Bel F, Heijnen CJ. 2014. Intranasal administration of human MSC for ischemic brain injury in the mouse: in vitro and in vivo neuroregenerative functions. PLoS One 9:e112339.
14. Donega V, Nijboer CH, van Velthoven CT, Youssef SA, de Bruin A, van Bel F, Kavelaars A, Heijnen CJ. 2015. Assessment of long-term safety and efficacy of intranasal mesenchymal stem cell treatment for neonatal brain injury in the mouse. Pediatr Res 78:520–526.
15. Duncan ID, Brower A, Kondo Y, Curlee JF Jr, Schultz RD. 2009. Extensive remyelination of the CNS leads to functional recovery. Proc Natl Acad Sci U S A 106:6832–6836.
16. Dzietko M, Faustino J, Derugin N, Wendland MF, Ferriero DM, Vexler ZS. 2011. MRI as a translational tool for the study of neonatal stroke. J Child Neurol 26:1145–1153.
17. Fancy SP, Chan JR, Baranzini SE, Franklin RJ, Rowitch DH. 2011. Myelin regeneration: a recapitulation of development? Annu Rev Neurosci 34:21–43.
18. Faustino J, Wang X, Jonhson C, Klibanov A, Derugin N, Wendland M, Vexler ZS. 2011. Microglial cells contribute to endogenous brain defenses after acute neonatal focal stroke. J Neurosci 31:12992–13001.
19. Franklin RJ, Ffrench-Constant C. 2008. Remyelination in the CNS: from biology to therapy. Nat Rev Neurosci 9:839–855.
20. Giunti D, Parodi B, Cordano C, Uccelli A, Kerlero de Rosbo N. 2014. Can we switch microglia's phenotype to foster neuroprotection? Focus on multiple sclerosis. Immunology 141:328–339.
21. Horie N, Pereira MP, Niizuma K, Sun G, Keren-Gill H, Encarnacion A, Shamloo M, Hamilton SA, Jiang K, Huhn S, et al. 2011. Transplanted stem cell-secreted vascular endothelial growth factor effects poststroke recovery, inflammation, and vascular repair. Stem Cells 29:274–285.
22. Iwai M, Stetler RA, Xing J, Hu X, Gao Y, Zhang W, Chen J, Cao G. 2010. Enhanced oligodendrogenesis and recovery of neurological function by erythropoietin after neonatal hypoxic/ischemic brain injury. Stroke 41:1032–1037.
23. Jaramillo-Merchan J, Jones J, Ivorra JL, Pastor D, Viso-Leon MC, Armengol JA, Molto MD, Geijo-Barrientos E, Martinez S. 2013. Mesenchymal stromal-cell transplants induce oligodendrocyte progenitor migration and remyelination in a chronic demyelination model. Cell Death Dis 4:e779.
24. Laroni A, Novi G, Kerlero de Rosbo N, Uccelli A. 2013. Towards clinical application of mesenchymal stem cells for treatment of neurological diseases of the central nervous system. J Neuroimmune Pharmacol 8:1062–1076.
25. Liu X, Ye R, Yan T, Yu SP, Wei L, Xu G, Fan X, Jiang Y, Stetler RA, Liu G, et al. 2014. Cell based therapies for ischemic stroke: from basic science to bedside. Prog Neurobiol 115:92–115.
26. Lodygensky GA, West T, Moravec MD, Back SA, Dikranian K, Holtzman DM, Neil JJ. 2011. Diffusion characteristics associated with neuronal injury and glial activation following hypoxia-ischemia in the immature brain. Magn Reson Med 66:839–845.
27. Mahmood A, Lu D, Chopp M. 2004. Intravenous administration of marrow stromal cells (MSCs) increases the expression of growth factors in rat brain after traumatic brain injury. J Neurotrauma 21:33–39.
28. Manabat C, Han BH, Wendland M, Derugin N, Fox CK, Choi J, Holtzman DM, Ferriero DM, Vexler ZS. 2003. Reperfusion differentially induces caspase-3 activation in ischemic core and penumbra after stroke in immature brain. Stroke 34:207–213.
29. McQuillen PS, Ferriero DM. 2004. Selective vulnerability in the developing central nervous system. Pediatr Neurol 30:227–235.
30. Mori S, Zhang J. 2006. Principles of diffusion tensor imaging and its applications to basic neuroscience research. Neuron 51:527–539.
31. Mu D, Jiang X, Sheldon RA, Fox CK, Hamrick SE, Vexler ZS, Ferriero DM. 2003. Regulation of hypoxia-inducible factor 1alpha and induction of vascular endothelial growth factor in a rat neonatal stroke model. Neurobiol Dis 14:524–534.
32. Nave KA, Werner HB. 2014. Myelination of the nervous system: mechanisms and functions. Annu Rev Cell Dev Biol 30:503–533.
33. Pantoni L, Garcia JH, Gutierrez JA. 1996. Cerebral white matter is highly vulnerable to ischemia. Stroke 27:1641–1646.
34. Partridge SC, Mukherjee P, Berman JI, Henry RG, Miller SP, Lu Y, Glenn OA, Ferriero DM, Barkovich AJ, Vigneron DB. 2005. Tractography-based quantitation of diffusion tensor imaging parameters in white matter tracts of preterm newborns. J Magn Reson Imaging 22:467–474.
35. Rivera FJ, Couillard-Despres S, Pedre X, Ploetz S, Caioni M, Lois C, Bogdahn U, Aigner L. 2006. Mesenchymal stem cells instruct oligodendrogenic fate decision on adult neural stem cells. Stem Cells 24:2209–2219.
36. Roze E, Harris PA, Ball G, Elorza LZ, Braga RM, Allsop JM, Merchant N, Porter E, Arichi T, Edwards AD, et al. 2012. Tractography of the corticospinal tracts in infants with focal perinatal injury: comparison with normal controls and to motor development. Neuroradiology 54:507–516.
37. Salinas Tejedor L, Berner G, Jacobsen K, Gudi V, Jungwirth N, Hansmann F, Gingele S, Prajeeth CK, Baumgartner W, Hoffmann A, et al. 2015. Mesenchymal stem cells do not exert direct beneficial effects on CNS remyelination in the absence of the peripheral immune system. Brain Behav Immun 50:155–165.
38. Semple BD, Blomgren K, Gimlin K, Ferriero DM, Noble-Haeusslein LJ. 2013. Brain development in rodents and humans: identifying benchmarks of maturation and vulnerability to injury across species. Prog Neurobiol 106–107:1–16.
39. Shen LH, Li Y, Gao Q, Savant-Bhonsale S, Chopp M. 2008. Down-regulation of neurocan expression in reactive astrocytes promotes axonal regeneration and facilitates the neurorestorative effects of bone marrow stromal cells in the ischemic rat brain. Glia 56:1747–1754.
40. Sizonenko SV, Camm EJ, Garbow JR, Maier SE, Inder TE, Williams CE, Neil JJ, Huppi PS. 2007. Developmental changes and injury induced disruption of the radial organization of the cortex in the immature rat brain revealed by in vivo diffusion tensor MRI. Cereb Cortex 17:2609–2617.
41. Stone BS, Zhang J, Mack DW, Mori S, Martin LJ, Northington FJ. 2008. Delayed neural network degeneration after neonatal hypoxia-ischemia. Ann Neurol 64:535–546.
42. Syed YA, Baer AS, Lubec G, Hoeger H, Widhalm G, Kotter MR. 2008. Inhibition of oligodendrocyte precursor cell differentiation by myelin-associated proteins. Neurosurg Focus 24:E5.
43. Tuor UI, Morgunov M, Sule M, Qiao M, Clark D, Rushforth D, Foniok T, Kirton A. 2014. Cellular correlates of longitudinal diffusion tensor imaging of axonal degeneration following hypoxic-ischemic cerebral infarction in neonatal rats. Neuroimage Clin 6:32–42.
44. van Velthoven CT, Kavelaars A, van Bel F, Heijnen CJ. 2010a. Mesenchymal stem cell treatment after neonatal hypoxic-ischemic brain injury improves behavioral outcome and induces neuronal and oligodendrocyte regeneration. Brain Behav Immun 24:387–393.
45. van Velthoven CT, Kavelaars A, van Bel F, Heijnen CJ. 2010b. Nasal administration of stem cells: a promising novel route to treat neonatal ischemic brain damage. Pediatr Res 68:419–422.
46. van Velthoven CT, Kavelaars A, van Bel F, Heijnen CJ. 2010c. Repeated mesenchymal stem cell treatment after neonatal hypoxia-ischemia has distinct effects on formation and maturation of new neurons and oligodendrocytes leading to restoration of damage, corticospinal motor tract activity, and sensorimotor function. J Neurosci 30:9603–9611.
47. van Velthoven CT, Kavelaars A, van Bel F, Heijnen CJ. 2011. Mesenchymal stem cell transplantation changes the gene expression profile of the neonatal ischemic brain. Brain Behav Immun 25:1342–1348.
48. van Velthoven CT, Sheldon RA, Kavelaars A, Derugin N, Vexler ZS, Willemen HL, Maas M, Heijnen CJ, Ferriero DM. 2013. Mesenchymal stem cell transplantation attenuates brain injury after neonatal stroke. Stroke 44:1426–1432.
49. Wang S, Wu EX, Tam CN, Lau HF, Cheung PT, Khong PL. 2008. Characterization of white matter injury in a hypoxic-ischemic neonatal rat model by diffusion tensor MRI. Stroke 39:2348–2353.
50. Zacharek A, Chen J, Cui X, Li A, Li Y, Roberts C, Feng Y, Gao Q, Chopp M. 2007. Angiopoietin1/Tie2 and VEGF/Flk1 induced by MSC treatment amplifies angiogenesis and vascular stabilization after stroke. J Cereb Blood Flow Metab 27:1684–1691.
51. Zaidi AU, Bessert DA, Ong JE, Xu H, Barks JD, Silverstein FS, Skoff RP. 2004. New oligodendrocytes are generated after neonatal hypoxic-ischemic brain injury in rodents. Glia 46:380–390.
52. Zhang J, Li Y, Chen J, Yang M, Katakowski M, Lu M, Chopp M. 2004. Expression of insulin-like growth factor 1 and receptor in ischemic rats treated with human marrow stromal cells. Brain Res 1030:19–27.